title: [Effects and mechanisms of ursodeoxycholic acid on isoprenaline-Induced myocardial fibrosis in mice].
abstract: Objective:To investigate the effects and possible mechanisms of ursodeoxycholic acid (UDCA) on myocardial fibrosis in mice.Method:To observe the expression of transforming growth factor(TGF) -β1, CTGF, MMPs and the degree of myocardial fibrosis, 61 male Kunming mice were randomly divided into normal group, low dose UDCA group, high dose of UDCA group, spironolactone group, and the control group.Isoproterenol (ISO) injection was given subcutaneously (30 d) to make the model of myocardial fibrosis.Corresponding anti-fibrosis drugs (UDCA or spironolactone) were given by gavage.HE staining and Masson staining were performed to explore the inflammation and fibrosis in the myocardium.The expression of collagen Ⅰ and collagen Ⅲ protein was detected by immunohistochemistry to evaluate the degree of fibrosis among the groups.Western blot was used to detect the expression of transforming growth factor, (TGF)-β1, connective tissue growth factor (CTGF), matrix metalloproteinase (MMP)-2, -9, tissue inhibitor of metalloproteinase (TIMP)-4, -1 and anti-phospho-NFKBIA (p-IκB-α) inhibitor of NF-κB (IκB) protein in myocardium.Results:HE and Masson staining results showed that in the normal group, myocardial fibrosis is less, while the control group showed a large amount of fibrotic tissue (P<0.05). Tissue fibrosis in the low/high dose UDCA group and spironolactone group was significantly reduced compared with the control group (P<0.05), in which high dose of UDCA reduces fibrosis more significantly.Immunohistochemistry results showed that collagen Ⅰ and collagen Ⅲ protein expression was significantly increased (P<0.05). Whereas in the low/high UDCA dose group and spironolactone group, collagen Ⅰ and collagen Ⅲ expression were significantly decreased (P<0.05), the high UDCA dose group decreased more significantly.Western blot results suggest that TGFβ-1 expression in the myocardial tissue was significantly increased compared to the normal group (P<0.05), whereas low/high UDCA dose group and spironolactone group, TGFβ-1 protein expression were significantly decreased [UDCA(1.52±0.16), (1.02±0.12), (1.01±0.21)vs (2.73±0.12),P<0.05], in which high UDCA dose group TGFβ-1 protein expression level decreased more significantly.However, there was no significant difference in the expression of CTGF, MMP2/9 and TIMP1/4 protein among the groups (P>0.05). UDCA decrease p-IκB-α expression and increase IκB protein expression dose-dependently.Conclusions:UDCA can relieve isoproterenol induced myocardial fibrosis and reduce the myocardial collagen Ⅰ and collagen Ⅲ deposition in a dose dependent manner.Down-regulating of TGFβ-1 protein expression through the inhibition of TGR5-NF-κB signal transduction pathway might be a potential mechanism underlying UDCA's effects.
authors.affiliation: Department of Cardiovascular Diseases, the First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
authors.forename: X
authors.initials: X
authors.lastname: Li
authors.forename: K Q
authors.initials: KQ
authors.lastname: Han
authors.forename: Y N
authors.initials: YN
authors.lastname: Shi
authors.forename: S Z
authors.initials: SZ
authors.lastname: Men
authors.forename: S
authors.initials: S
authors.lastname: Li
authors.forename: M H
authors.initials: MH
authors.lastname: Sun
authors.forename: H
authors.initials: H
authors.lastname: Dong
authors.forename: J J
authors.initials: JJ
authors.lastname: Lu
authors.forename: L J
authors.initials: LJ
authors.lastname: Ma
authors.forename: M
authors.initials: M
authors.lastname: Zhao
authors.forename: D
authors.initials: D
authors.lastname: Li
authors.forename: W
authors.initials: W
authors.lastname: Liu
mesh_terms: D000818:Animals; D009202:Cardiomyopathies; D003094:Collagen; D055513:Connective Tissue Growth Factor; D015536:Down-Regulation; D005355:Fibrosis; D007545:Isoproterenol; D008297:Male; D051379:Mice; D009206:Myocardium; D000072000:NF-KappaB Inhibitor alpha; D016328:NF-kappa B; D015398:Signal Transduction; D019715:Tissue Inhibitor of Metalloproteinase-1; D053773:Transforming Growth Factor beta1; D014580:Ursodeoxycholic Acid
chemical_list: D016328:NF-kappa B; C000606204:NFKBIA protein, human; C508960:TGFB1 protein, human; C560822:TIMP1 protein, human; D019715:Tissue Inhibitor of Metalloproteinase-1; D053773:Transforming Growth Factor beta1; D055513:Connective Tissue Growth Factor; D000072000:NF-KappaB Inhibitor alpha; D014580:Ursodeoxycholic Acid; D003094:Collagen; D007545:Isoproterenol
keywords: Collagen; Isopreterenol; Myocardial diseases; Ursodeoxycholic acid